In second Covid wave, other fungi may thrive: Doctors

While state has reported serious black fungus cases, white & yellow fungal infection has also been reported in other parts of  country

Published: 27th May 2021 06:28 AM  |   Last Updated: 27th May 2021 06:28 AM   |  A+A-

illus| express

Express News Service

THIRUVANANTHAPURAM: It is not just black fungus, but the widespread use of immunity-suppressing medicines and poor management of diabetes seen during the second wave of Covid, which can also attract a host of other types of fungal attacks, according to the health experts.

Patients with serious cases of black fungus (mucormycosis) infection  have been reported in the state, while fungal infections such as white fungus (Candida and Aspergillus) and yellow fungus have been reported in other parts of the country. Though the fungal infections have always troubled patients with compromised immunity, the second wave of pandemic warranted an enhanced vigil over the situation. 

“The rise in the number of Covid patients during the second wave created a favourable condition for all kinds of opportunistic fungus,” said K P Aravindan,  pathologist and member of the Covid-19 expert panel. According to him, it is important to ensure easy availability of drugs used to treat fungal infections. 

At the peak of the second wave,  the state had around 4.5 lakh active Covid patients. The total number of confirmed patients also crossed 24 lakh. The heavy caseload also contributed to the rise in fungal infection. 

“As the caseload increases, the attention given to comorbidities wanes. So conditions like uncontrolled diabetes and indiscriminate use of medicine arise, providing a favourable condition for fungal attacks,” said Vishad Viswanath, a consultant rheumatologist. He also pointed out the possibility of ignoring the early symptoms of fungal attacks since such systemic infections were not common. Though chances of fungal infection have increased, the situation has not become alarming yet, he said. 

The medicine used for treating fungal infection is in short supply as the government streamlines the supply side. According to R C Sreekumar, chairman of research cell of Indian Medical Association (IMA),  the hospitals did not regularly stock the medicines because the instances were few. Four out of 10 hospitals stocked the anti-fungal medicines, he said. 


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp